Shore Capital Partners sells ClearPath Diagnostics
Shore Capital Partners, a healthcare-focused private equity firm, has sold ClearPath Diagnostics, a provider of laboratory diagnostic services in the north-eastern US, to Laboratory Corporation of America (LabCorp). Shore Capital partnered with ClearPath’s founding pathologists, Dr Michael Jozefczyk and Dr Michael Mazur, to drive the company’s expansion beyond the local